ICMR probes AstraZeneca shot response

The Indian Council of Medical Research (ICMR) is inquiring about the alleged negative reaction during AstraZeneca’s COVID-19 vaccine trials. However, they found no evidence to halt the proceedings, stated a senior official, on Sunday.

In a complaint, a 40-year-old man stated he had suffered from “neurological and psychological” reactions post the vaccine trails run by the British drugmaker’s partner Serum Institute of India, on him.


Samiran Panda, head of Epidemiology and Communicable Diseases at the ICMR said, “There was no immediate cause of concern at this stage.” Additionally, “It doesn’t mean that long term assessment will not happen, it is still happening. I am aware of the activity.”

Law firm N.G.R. Prasad & R. Rajaram Advocates sent the complaint by the unnamed volunteer, who is suing manufacturing and distribution of the vaccine, ICMR, SII, AstraZeneca, and the Drug Controller General of India for 50 million rupees. He demands the suspension of testing.

SII (Serum Institute of India) said, “While the Serum Institute of India is sympathetic with the volunteer’s medical condition, there’s absolutely no correlation with the vaccine trials.” Additionally, “The volunteer was specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent.”

AstraZeneca and the Drugs Controller General of India remained silent on the issue.